Insomnia News and Research

Latest Insomnia News and Research

Targeting symptoms, rather than disorders, might help reduce work impact of mental health issues

Targeting symptoms, rather than disorders, might help reduce work impact of mental health issues

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

Technology increases cognitive behavioral therapy options for insomnia

Technology increases cognitive behavioral therapy options for insomnia

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Persistent insomnia symptom risk high

Persistent insomnia symptom risk high

Merck announces FDA approval of ISENTRESS for oral suspension

Merck announces FDA approval of ISENTRESS for oral suspension

Support for DSM-5 mixed features specifier

Support for DSM-5 mixed features specifier

Research: Daily meditation may improve symptoms of anxiety and depression

Research: Daily meditation may improve symptoms of anxiety and depression

Sleep duration predicts chronic depression and anxiety

Sleep duration predicts chronic depression and anxiety

Japanese FIRST tool assesses vulnerability to insomnia

Japanese FIRST tool assesses vulnerability to insomnia

St. Louis College of Pharmacy's Amy Tiemeier suggests four easy resolutions for a healthier 2014

St. Louis College of Pharmacy's Amy Tiemeier suggests four easy resolutions for a healthier 2014

Toddlers’ bedtime resistance may contribute to sleep problems

Toddlers’ bedtime resistance may contribute to sleep problems

Insomnia impact on sleepiness and vigilance performance differs by age

Insomnia impact on sleepiness and vigilance performance differs by age

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Researchers develop first test to identify acute mountain sickness

Researchers develop first test to identify acute mountain sickness

Dietary amino acids improve sleep disturbances caused by brain injuries in animals

Dietary amino acids improve sleep disturbances caused by brain injuries in animals

Insomnia linked to increased GERD risk

Insomnia linked to increased GERD risk

Insomnia symptoms linked to increased mortality

Insomnia symptoms linked to increased mortality

San Diego School of Medicine receives grant to provide professional training to senior drivers

San Diego School of Medicine receives grant to provide professional training to senior drivers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.